Search results
Showing 571 to 585 of 888 results for community guidance
numbers of patients dying with non-malignant diseases in hospitals and in community care. Anti-muscarinic agents may have undesired side...
Evaluation of these factors could be used to inform future NICE guidance, for example, specific guidance for management of...
This quality standard covers the health and wellbeing of looked-after children and young people (from birth to 18 years) and care leavers (including young people planning to leave care or under leaving care provisions). It is for all settings and services that work with and care for looked-after children and young people, wherever they are living (for example, with family or friends, with foster families or in residential care). It describes high-quality care in priority areas for improvement.
View quality statements for QS31Show all sections
Sections for QS31
- Quality statements
- Quality statement 1: Warm, nurturing care
- Quality statement 2: Collaborative working between services and professionals
- Quality statement 3: Stability and quality of placements
- Quality statement 4: Support to explore and make sense of identity and relationships
- Quality statement 5: Support from specialist and dedicated services
- Quality statement 6: Continuity of services for placements outside the local authority or health boundary
- Quality statement 7: Support to fulfil potential
complement the Care Act 2014, other associated care and support statutory guidance, and the Children and Families Act 2014. These set...
Function Classification System (GMFCS) level II or III result in good community mobility as a young adult? Any explanatory notes(if...
Evidence-based recommendations on 3C Patch for treating diabetic foot ulcers.
NICE has developed a medtech innovation briefing (MIB) on LQD Spray for treating acute and chronic wounds .
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
View quality statements for QS199Show all sections
Sections for QS199
- Quality statements
- Quality statement 1: Access to abortion services
- Quality statement 2: Choice of abortion procedure
- Quality statement 3: Waiting time for an abortion
- Quality statement 4: Early medical abortion
- Quality statement 5: Contraception
- Quality statement 6: Support after an abortion
- Update information
collaboration between the Hip Fracture Programme team, care-home staff and other community-based professionals and (2) a cluster...
member, your insights help equip health and care practitioners with the guidance they need to deliver the best care. Get involved Our...
Find out more about the types of organisations that can register to be a stakeholder at NICE.
This guideline sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over. It aims to optimise antibiotic use and reduce antibiotic resistance.
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Summary of the evidence on oral magnesium glycerophosphate for preventing recurrent hypomagnesaemia to inform local NHS planning and decision-making
Early value assessment (EVA) guidance on digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments.